- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 17.87M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $60M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $31.37M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $20.58M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $45.73M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $56.75M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $66.63M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $63.3M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $157.41M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $160.69M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $146.56M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $135.1M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $175.97M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $163.98M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 17.52M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$5.01M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$31.67M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$28.64M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.47 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.47 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $28.45M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$8.25M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$6.97M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.03M |
| Revenue | Q1 2025 · Mar 31, 2024 | $29.53M |